Ads
related to: clinical research analyst
Search results
What is a clinical data analyst? | Definition from TechTarget
SearchSecurity.com· 2 days agoThe purpose of these data analytics is to verify that processes and protocols are followed, improving the quality and efficiency of healthcare. This clinical data management ...
William Blair Research Analysts Boost Earnings Estimates for Ovid Therapeutics Inc. (NASDAQ:OVID)
ETF DAILY NEWS· 20 hours agoOvid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities research analysts at William Blair raised their Q2 2025 earnings per share estimates for shares ...
Analyst Report: IQVIA Holdings Inc
Argus Research via Yahoo Finance· 4 hours agoIQVIA is headquartered in Research Triangle Park, North Carolina. IQVIA provides advanced analytics, technology solutions, and clinical research ...
Alector (NASDAQ:ALEC) Receives Overweight Rating from Cantor Fitzgerald
ETF DAILY NEWS· 13 hours agoAlector (NASDAQ:ALEC – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Cantor Fitzgerald in a research ...
Spirit Aero downgraded, Skyworks upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 8 hours agoUBS downgraded Zentalis (ZNTL) to Neutral from Buy with a price target of $5, down from $28. The...
Equities Analysts Offer Predictions for Vistagen Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:VTGN)
ETF DAILY NEWS· 7 days agoVistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates ...
Skye Bioscience (NASDAQ:SKYE) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 2 days agoSkye Bioscience (NASDAQ:SKYE – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a research ...
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Consensus Recommendation of “Buy” by Brokerages
ETF DAILY NEWS· 21 hours agoZevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) has been given an average rating of “Buy” by the six ratings firms that are covering the stock, MarketBeat.com reports. Six equities ...
Here's Why Icon PLC (ICLR) is a Strong Momentum Stock
Zacks via Yahoo Finance· 8 hours agoThe company is a provider of outsourced development and services to pharmaceutical, biotechnology,...
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Rating of “Moderate Buy” from Analysts
ETF DAILY NEWS· 20 hours agoTwo equities research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has given a strong buy recommendation ...
